Discover highlights from FY2026 ICD-10-CM official guidelines

Why This Topic Matters

Annual guideline updates can change how documentation is interpreted and reported across high-volume diagnoses and encounters. Staying aligned with the FY2026 ICD-10-CM guidance helps support consistent code assignment, documentation review, and reporting processes.

Article Sections

1. Overview of FY2026 guideline updates

   Introduces the scope and effective timing of selected FY2026 ICD-10-CM guideline changes. Summarizes the main subject areas addressed in the article.

2. HIV-related guideline updates

   Covers changes in Chapter 1 guidance related to HIV documentation and status reporting. Focuses on how the updated language affects common infectious disease coding scenarios.

3. Antineoplastic therapy encounter guidance

   Summarizes revised guidance for encounters involving cancer-directed therapies in Chapter 2. Addresses the broader handling of treatment-related admissions and encounters.

4. Diabetes in remission

   Describes new Chapter 4 guidance concerning documentation of remission status for diabetes. Highlights the documentation theme addressed by the update.

5. Multiple sites

   Explains the added guidance for diagnoses documented at more than one site. Notes how the article frames this topic across general and chapter-specific coding guidance.

6. Hypertension with heart disease

   Reviews updated Chapter 9 guidance involving hypertension and related heart conditions. Covers the cardiovascular coding topic addressed by the revision.

7. Body mass index (BMI) updates

   Summarizes revised Chapter 21 guidance for BMI reporting. Focuses on documentation requirements and circumstances discussed in the update.